Support program for breast cancer survivors
Part of Cancer clinical trials.
This study tests a program designed to help women who have had a mastectomy feel more supported and resilient. It may be a good fit if you are a breast cancer survivor interested in emotional and social support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 65 years old.
- You have had a mastectomy.
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mindfulness-based program designed to help women with breast cancer develop self-compassion and coping skills. It may reduce stress and improve emotional well-being during treatment or recovery.
This study tests a web-based program designed to help breast cancer survivors manage fears that their cancer might return. It compares the program to usual care to see if it reduces worry and improves quality of life.
This study tests a video-based exercise program for people who recently had breast cancer surgery. It aims to help with recovery by providing guided exercises you can do at home.
This trial tests a lifestyle adjustment program for women who have finished chemotherapy for early-stage breast cancer. It aims to help you make healthy changes and improve your well-being.
This trial tests a type of talk therapy called Acceptance and Commitment Therapy in online group sessions for people with breast cancer. The goal is to see if it helps you cope better during chemotherapy.
This study tests a counseling program designed to help women with metastatic breast cancer build resilience and cope better. If you've been diagnosed within the last 6 months and get your cancer care at UNC, you may be eligible.
Hear when a new Mastectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.